Cibc World Markets Corp Purchases 16,984 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cibc World Markets Corp grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 418,371 shares of the healthcare conglomerate’s stock after acquiring an additional 16,984 shares during the period. UnitedHealth Group accounts for approximately 1.2% of Cibc World Markets Corp’s investment portfolio, making the stock its 14th biggest position. Cibc World Markets Corp’s holdings in UnitedHealth Group were worth $211,637,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $488.52 on Monday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company’s 50 day moving average price is $511.36 and its two-hundred day moving average price is $549.80. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $446.85 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent analyst reports. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.